Exact Mass: 587.1251

Exact Mass Matches: 587.1251

Found 48 metabolites which its exact mass value is equals to given mass value 587.1251, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Celecoxib glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{4-[1-(4-sulfamoylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoyloxy}oxane-2-carboxylic acid

C23H20F3N3O10S (587.0821)


Celecoxib glucuronide is a metabolite of celecoxib and is only found in individuals that have used or taken this drug (PMID: 10681375). Celecoxib (trade name: Celebrex) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation, and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. Celecoxib is available by prescription in capsule form (Wikipedia).

   

Benzenemethanol, 4-(1-(3,4-bis(difluoromethoxy)phenyl)-2-(3-methyl-1-oxido-4-pyridinyl)ethyl)-alpha,alpha-bis(trifluoromethyl)-

4-{2-[3,4-bis(difluoromethoxy)phenyl]-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]ethyl}-3-methylpyridin-1-ium-1-olate

C25H19F10NO4 (587.1154)


   

(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid

3-[(4-{1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)formamido]propanoic acid

C32H27Cl2N3O4 (587.1379)


   

Quinoline, 6-(1-methyl-1-(methylsulfonyl)ethyl)-8-(3-((1E)-2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)ethenyl)phenyl)-

Quinoline, 6-(1-methyl-1-(methylsulfonyl)ethyl)-8-(3-((1E)-2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)ethenyl)phenyl)-

C31H29N3O5S2 (587.1549)


   
   
   
   
   
   

hydroxycyclochlorotine A

hydroxycyclochlorotine A

C24H31Cl2N5O8 (587.155)


   

N-Hexadecanoyldeacylconvoltamide

N-Hexadecanoyldeacylconvoltamide

C26H39Br2NO4 (587.1246)


   
   
   

((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)METHYL)TRIPHENYLPHOSPHONIUM IODIDE

((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)METHYL)TRIPHENYLPHOSPHONIUM IODIDE

C29H35INO2P (587.145)


   

[4-(2,4-difluorophenyl)-2-[[4-nitro-3-(trifluoromethyl)phenyl]carbamoyl]phenyl] 4-nitrobenzoate

[4-(2,4-difluorophenyl)-2-[[4-nitro-3-(trifluoromethyl)phenyl]carbamoyl]phenyl] 4-nitrobenzoate

C27H14F5N3O7 (587.0752)


   

Tradipitant

Tradipitant

C28H16ClF6N5O (587.0948)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tradipitant (VLY-686) is a neurokinin-1 (NK-1) antagonist.

   

Phosphoramidon disodium salt

Phosphoramidon disodium salt

C23H32N3Na2O10P (587.1621)


   

MK 0893

(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid

C32H27Cl2N3O4 (587.1379)


   

6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE

6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE

C31H29N3O5S2 (587.1549)


   
   

Vestipitant Mesylate

Vestipitant Mesylate

C24H28F7N3O4S (587.1689)


C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

   

3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-YL)-1H-pyrazol-1-YL)ethyl)benzamido)propanoic acid

3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-YL)-1H-pyrazol-1-YL)ethyl)benzamido)propanoic acid

C32H27Cl2N3O4 (587.1379)


   

(Z)-8-(3-(2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)vinyl)phenyl)-6-(2-(methylsulfonyl)propan-2-yl)quinoline

(Z)-8-(3-(2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)vinyl)phenyl)-6-(2-(methylsulfonyl)propan-2-yl)quinoline

C31H29N3O5S2 (587.1549)


   

dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose(2-)

dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose(2-)

C18H27N3O15P2-2 (587.0917)


   
   

dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose(2-)

dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose(2-)

C18H27N3O15P2-2 (587.0917)


   

dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose(2-)

dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose(2-)

C18H27N3O15P2-2 (587.0917)


   

dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose

dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose

C18H27N3O15P2-2 (587.0917)


   

GDP-4-amino-4,6-dideoxy-alpha-D-mannose(1-)

GDP-4-amino-4,6-dideoxy-alpha-D-mannose(1-)

C16H25N6O14P2- (587.0904)


   

1-[2-[3-Carboxylato-5-[[3-carboxylato-3-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

1-[2-[3-Carboxylato-5-[[3-carboxylato-3-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

C22H25N3O16-4 (587.1235)


   
   

dTDP-alpha-D-rubranitrose

dTDP-alpha-D-rubranitrose

C18H27N3O15P2-2 (587.0917)


   

dTDP-4-acetamido-4,6-dideoxy-D-galactose

dTDP-4-acetamido-4,6-dideoxy-D-galactose

C18H27N3O15P2-2 (587.0917)


   

1-[1-carboxylato-3-({(3R)-3-carboxylato-5-[2-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-3-hydroxy-5-oxopentanoyl}amino)propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

1-[1-carboxylato-3-({(3R)-3-carboxylato-5-[2-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-3-hydroxy-5-oxopentanoyl}amino)propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

C22H25N3O16-4 (587.1235)


   

dTDP-4-acetamido-4,6-dideoxy-D-glucose(2-)

dTDP-4-acetamido-4,6-dideoxy-D-glucose(2-)

C18H27N3O15P2-2 (587.0917)


   

Guanylyl-3,5-cytidine(1-)

Guanylyl-3,5-cytidine(1-)

C19H24N8O12P- (587.1251)


   

Phosphoramidon (Disodium)

Phosphoramidon (Disodium)

C23H32N3Na2O10P (587.1621)


Phosphoramidon Disodium, a microbial metabolite, is a specific metalloprotease thermolysin inhibitor with an IC50 of 0.4 μg/mL. Phosphoramidon Disodium also inhibits endothelin-converting enzyme (ECE), neutral endopeptidase (NEP), and angiotensin-converting enzyme (ACE) with IC50 values of 3.5, 0.034, and 78 μM, respectively[1][2][3].

   

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

C28H26BrN7O3 (587.128)


   

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

(2's,3's,4r)-2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

C28H26BrN7O3 (587.128)


   

17,18-dichloro-1,4,7,11-tetrahydroxy-3-(1-hydroxyethyl)-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

17,18-dichloro-1,4,7,11-tetrahydroxy-3-(1-hydroxyethyl)-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O8 (587.155)


   

methyl (2r,7r,8s)-8-bromo-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-2h,3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

methyl (2r,7r,8s)-8-bromo-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-2h,3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

C26H26BrN3O8 (587.0903)


   

methyl (2r,8s)-8-(bromomethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate

methyl (2r,8s)-8-(bromomethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h-pyrrolo[3,2-e]indole-2-carboxylate

C26H26BrN3O8 (587.0903)


   

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-1,4,7,11-tetrahydroxy-3-[(1r)-1-hydroxyethyl]-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-1,4,7,11-tetrahydroxy-3-[(1r)-1-hydroxyethyl]-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O8 (587.155)


   

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

C26H39Br2NO4 (587.1246)


   

2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

2'-(6-bromo-1h-indol-3-yl)-2''-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2,5,5''-trione

C28H26BrN7O3 (587.128)


   

3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

3-(3,4-dibromo-5-hydroxyphenyl)-1-hexadecanoyl-3-hydroxypyrrolidin-2-one

C26H39Br2NO4 (587.1246)


   

2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

2'-(6-bromo-1h-indol-3-yl)-2-imino-1,1'',3,3''-tetramethyl-4',9'-dihydro-2'h-dispiro[imidazolidine-4,1'-carbazole-3',4''-imidazolidine]-2'',5,5''-trione

C28H26BrN7O3 (587.128)


   

methyl (2r,8s)-8-bromo-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

methyl (2r,8s)-8-bromo-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-3h,7h,8h,9h-pyrrolo[3,2-f]quinoline-2-carboxylate

C26H26BrN3O8 (587.0903)